Massimo Breda

Nerviano Medical Sciences

Papers

1

Total Citations

49

H-Index

1

About

Massimo Breda is a distinguished researcher in the field of bioanalytical chemistry and pharmaceutical sciences, with a primary focus on the quantitative analysis of anticancer agents in biological matrices. His most notable contribution is the development of a semi-automated liquid–liquid extraction method coupled with liquid chromatography/tandem mass spectrometry (LC-MS/MS) for the precise determination of paclitaxel in human plasma, a technique that has garnered 49 citations and remains a benchmark for therapeutic drug monitoring. This work exemplifies his expertise in advancing high-throughput, sensitive analytical methodologies to support pharmacokinetic studies and clinical pharmacology. Breda’s research has significantly enhanced the accuracy and efficiency of drug quantification in complex biological samples, directly impacting the safety and efficacy of chemotherapy regimens. His achievements underscore a commitment to bridging analytical innovation with clinical application, making his contributions invaluable for students and researchers exploring bioanalysis, drug metabolism, and personalized medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
Quantitative determination of paclitaxel in human plasma using semi-automated liquid–liquid extraction in conjunction with liquid chromatography/tandem mass spectrometry
49 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Nerviano Medical Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago